Patients with obesity may exhibit variable HPA axis patterns, with some studies showing alterations in 24-hour urinary cortisol excretion despite normal serum cortisol levels, though these findings are heterogeneous across studies
Data on long-term side effects of Wegovy are still developing, but current evidence suggests that Wegovy is generally well tolerated
The model provides an alternative method of investigating and quantifying redox cycling induced oxidative stress, circumventing the experimental difficulties of measuring and tracking radical species
Tirzepatide is relatively new to market, only gaining FDA approval for weight loss (under Zepbound) in November 2023
However, in AP/CP there is marked increase in GLP-1R, primarily in PSCs
Tesamorelin for Visceral Fat Tesamorelin is a growth hormone releasing hormone (GHRH) analog FDA-approved for HIV-associated lipodystrophy